Andreas Halvorsen - Viking Global Investors
Holding/activity history for Amylyx Pharmaceuticals Inc (AMLX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.16 | SEC | ||
| 2023 Q4 | 2,962,555 | 0.16 | $14.72 | $43,608,810 | SEC | ||
| 2023 Q3 | 2,962,555 | 0.22 | $18.31 | $54,244,382 | SEC | ||
| 2023 Q2 | 2,962,555 | 0.26 | $21.57 | $63,902,311 | SEC | ||
| 2023 Q1 | 2,962,555 | 0.41 | Reduce 36.08% | 0.31 | $29.34 | $86,921,364 | SEC |
| 2022 Q4 | 4,634,606 | 0.86 | Reduce 19.68% | 0.15 | $36.95 | $171,248,692 | SEC |
| 2022 Q3 | 5,770,536 | 0.75 | Reduce 19.52% | 0.12 | $28.15 | $162,441,000 | SEC |
| 2022 Q2 | 7,170,536 | 0.63 | $19.26 | $138,105,000 | SEC | ||
| 2022 Q1 | 7,170,536 | 0.37 | Buy | 0.37 | $12.85 | $92,141,000 | SEC |